echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: METL3-mediated ATG7 m6A modification regulates the autophagy-GATA4 axis to promote cell senescence and osteoarthritis progression

    ARD: METL3-mediated ATG7 m6A modification regulates the autophagy-GATA4 axis to promote cell senescence and osteoarthritis progression

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    The long-term existence of senescent cells is closely related to the development of osteoarthritis ( OA )



    Collect the synovial tissues of normal patients and OA patients


    In patients and mouse models, as OA progresses, aging FLS increases significantly


    This study revealed the important role of FLS senescence in the progression of OA .


     

    Source:

    Chen X, Gong W, Shao X , et al METTL3-mediated m 6 A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression Annals of the Rheumatic DiseasesPublished Online First: 27 October 2021.


    Chen X, Gong W, Shao X , et al METTL3-mediated m 6 A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression , et al 6 Annals of the Rheumatic DiseasesAnnals of the Rheumatic DiseasesPublished Online First: 27 October 2021.
    doi: 10.
    1136/annrheumdis-2021-221091

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.